How safe are our clinical trials?
Popularity Report
![]() |
|||
![]() |
|||
![]() |
|||
![]() |
|||
![]() |
|||
![]() |
URL Tag Cloud
Bookmark History
Saved by 1 people (0 private), first by anonymouse user on 2008-08-27
- Gibreel on 2008-08-27 - Tags clinical-trials , drugs , pharma , pharmaceuticals , CROs , DCGI , ethics
Public Sticky notes
The way the actual testing works is that the sponsor clears every project with the Drug Controller General of India (DCGI) and, as part of the process, has to have a Management Committee, an Ethics Committee and a Data Safety Management Board; there are then various monitoring committees and the DCGI is training people to ensure these guidelines are being followed. The structures are all there and the larger trials, by the Bill and Melinda Gates Foundation for instance, are being done under these rules. But much of this is self-regulatory and there will be lapses. The rules and their implementation are being strengthened and as the support eco-system gets better, the chances of regulatory failure also decline. In another five years, India will have a very strong clinical trials environment in place
Highlighted by gibreel


Public Comment